Adrenal androgen levels as predictors of outcome in prostate cancer patients treated with ketoconazole plus antiandrogen withdrawal: results from a cancer and leukemia group B study.
- Citation:
- Clin Cancer Res vol 13 (7) 2030-7
- Year:
- 2007
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- CA31946
- Corr. Author:
- Authors:
- Charles J Ryan Susan Halabi San-San Ou Nicholas J Vogelzang Philip Kantoff Eric J Small
- Networks:
- Study
- CALGB-9583
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Adrenal Glands, Aged, Aged, 80 and over, Androgen Antagonists, Androgens, Drug Resistance, Neoplasm, Humans, Ketoconazole, Male, Middle Aged, Prostate-Specific Antigen, Prostatic Neoplasms, Treatment Outcome